Lack of associations between vitamin D metabolism-related gene variants and risk of colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 957-961

  Mahmoudi, Touraj ^a   Karimi, Khatoon ^a   Arkani, Maral ^a   Farahani, Hamid ^b   Nobakht, Hossein ^c   Dabiri, Reza ^c   Asadi, Asadollah ^d   Vahedi, Mohsen ^e   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF MOHAGHEGH ARDABILI   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colorectal cancer; CYP27B1; CYP2R1; GC; Lack of association; Risk; Variant; VDR

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR; CHOLESTANETRIOL 26 MONOOXYGENASE; CYP2R1 PROTEIN, HUMAN; TUMOR MARKER; VDR PROTEIN, HUMAN; VITAMIN; VITAMIN D; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHOLESTANETRIOL 26-MONOOXYGENASE; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, CALCITRIOL; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; VITAMIN D; VITAMIN D-BINDING PROTEIN; VITAMINS; YOUNG ADULT;

EID: 84894655057     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.957     Document Type: Article

References (23)

1. Bu FX, Armas L, Lappe J, et al (2010). Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum Genet, 128, 549-56.
2. Bureau JP, Henry L, Baz A, Scherrer K, Chateau MT (1997). Prosomes (proteasomes) changes during differentiation are related to the type of inducer. Mol Biol Rep, 24, 57-62.
3. Dong LM, Ulrich CM, Hsu L, et al (2009). Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev, 18, 2540-8.
4. Egan JB, Thompson PA, Vitanov MV, et al (2010). Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells. Mol Carcinog, 49, 337-52.
5. Fang Y, van Meurs JB, d'Alesio A, et al (2005). Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study. Am J Hum Genet, 77, 807-23.
6. Flugge J, Krusekopf S, Goldammer M, et al (2007). Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur J Clin Pharmacol, 63, 997-1005.
7. Guzey M, Kitada S, Reed JC (2002). Apoptosis induction by 1α, 25-Dihydroxyvitamin D3 in prostate cancer. Mol Cancer Ther, 1, 667-77.
8. Hibler EA, Hu C, Jurutka PW, Martinez ME, Jacobs ET (2012). Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev, 21, 368-75.
9. Howard G, Nguyen T, Morrison N, et al (1995). Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab, 80, 2800-5.
10. Hughes DJ, Hlavata I, Soucek P, et al (2011). Variation in the vitamin D receptor gene is not associated with risk of colorectal cancer in the Czech Republic. J Gastrointest Cancer, 42, 149-54.
11. Huncharek M, Muscat J, Kupelnick B (2009). Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer, 61, 47-69.
12. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001). Replication validity of genetic association studies. Nat Genet, 29, 306-9.
13. Jemal A, Tiwari RC, Murray T, et al (2004). American Cancer Society (2004) Cancer statistics. CA Cancer J Clin, 54, 8-29.
14. Kampman E, Slattery ML, Caan B, Potter JD (2000). Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control, 11, 459-466.
15. Mahmoudi T, Arkani M, Karimi K, et al (2012). The-4817 G>A (rs2238136) variant of the vitamin D receptor gene: a probable risk factor for colorectal cancer. Mol Biol Rep, 39, 5277-82.
16. Mahmoudi T, Karimi K, Mohebbi SR, Fatemi SR, Zali MR (2011). Start codon FokI and intron 8 BsmI variants in the vitamin D receptor gene and susceptibility to colorectal cancer. Mol Biol Rep, 38, 4765-70.
17. Palmer HG, Gonzalez-Sancho JM, Espada J, et al. (2001). Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J Cell Biol, 154, 369-87.
18. Poynter JN, Jacobs ET, Figueiredo JC, et al (2010). Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev, 19, 525-36.
19. Sinotte M, Diorio C, Bérubé S, Pollak M, Brisson J (2009). Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr, 89, 634-40.
20. Stein GS, Lian JB, Van Wijnen AJ, Stein JL (1997). The osteocalcin gene: a model for multiple parameters of skeletal-specific transcriptional control. Mol Biol Rep, 24, 185-96.
21. Woolcott CG, Wilkens LR, Nomura AM, et al (2010). Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: The multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 19, 130-4.
22. Zehnder D, Bland R, Williams MC, et al (2001). External expression of 25-hydroxyvitamin D(3)-1alpha hydroxylase. J Clin Endocrinol Metab, 86, 888-94.
23. Zhou L, Zhang X, Chen X, et al (2012). GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population. Int J Clin Exp Med, 5, 72-9.